Healthcare provider profile · identity verified

Archie D Enoch, MD

Family Practice · BEAVERCREEK, OH · NPI 1780683755

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	228	49
Atorvastatin Calcium	Atorvastatin Calcium	199	57
Trazodone Hcl	Trazodone Hcl	162	32
Omeprazole	Omeprazole	151	37
Levothyroxine Sodium	Levothyroxine Sodium	142	38
Amlodipine Besylate	Amlodipine Besylate	132	38
Lisinopril	Lisinopril	130	34
Albuterol Sulfate Hfa	Albuterol Sulfate	126	28
Methocarbamol	Methocarbamol	95	17
Metformin Hcl	Metformin Hcl	93	23
Tramadol Hcl	Tramadol Hcl	83	14
Buspirone Hcl	Buspirone Hcl	71	13
Eliquis	Apixaban	71	11
Meloxicam	Meloxicam	65	15
Furosemide	Furosemide	63	13
Montelukast Sodium	Montelukast Sodium	61	15
Pantoprazole Sodium	Pantoprazole Sodium	61	16
Tizanidine Hcl	Tizanidine Hcl	56	suppressed
Potassium Chloride	Potassium Chloride	54	16
Carvedilol	Carvedilol	51	13
Losartan Potassium	Losartan Potassium	51	18
Ondansetron Odt	Ondansetron	51	14
Sertraline Hcl	Sertraline Hcl	50	suppressed
Simvastatin	Simvastatin	50	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	suppressed
Metformin Hcl Er	Metformin Hcl	45	13
Rosuvastatin Calcium	Rosuvastatin Calcium	44	11
Duloxetine Hcl	Duloxetine Hcl	43	15
Hydroxyzine Pamoate	Hydroxyzine Pamoate	43	suppressed
Clonazepam	Clonazepam	42	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	13
Bupropion Xl	Bupropion Hcl	41	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Allopurinol	Allopurinol	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	12
Synthroid	Levothyroxine Sodium	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	19
Ozempic	Semaglutide	30	suppressed
Famotidine	Famotidine	29	12
Nifedipine Er	Nifedipine	29	suppressed
Promethazine Hcl	Promethazine Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Ibuprofen	Ibuprofen	28	11
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Glipizide	Glipizide	26	suppressed
Metoprolol Succinate	Metoprolol Succinate	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Naproxen	Naproxen	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Diazepam	Diazepam	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Atenolol	Atenolol	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Azithromycin	Azithromycin	17	16
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Atrovent Hfa	Ipratropium Bromide	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	14
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Indomethacin	Indomethacin	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	13	suppressed
Colchicine	Colchicine	13	suppressed
Linzess	Linaclotide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Epinephrine	Epinephrine	11	suppressed
Finasteride	Finasteride	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Prednisone	Prednisone	11	suppressed
Qulipta	Atogepant	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error